Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism-based Treatment for Painful Diabetic Neuropathy
NCT03276689Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Oct 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in diabetic neuropathy comparing Duloxetine, Pregabalin and Placebo (3 arms). Primary endpoint: Pain modulation profile at 8 weeks. Started Oct 2017; status: completed.
02
Drugs
duloxetinepregabalin
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT03276689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03276689.